Dina Kao on a trial of lyophilised sterile faecal filtrate versus lyophilised conventional donor stool for recurrent Clostridiodes difficile infection

The Lancet Gastroenterology & Hepatology in conversation with

The Lancet Gastroenterology & Hepatology in conversation with
Dina Kao on a trial of lyophilised sterile faecal filtrate versus lyophilised conventional donor stool for recurrent Clostridiodes difficile infection
Nov 28, 2025
The Lancet Group

Can bacteria-free, sterile faecal filtrate match conventional faecal microbiota transplantation for recurrent C difficile infection? Dina Kao (University of Alberta) unpacks a landmark multicentre trial that tested this hypothesis, and we discuss what it tells us about the role of living organisms in the therapeutic effects of microbiota-based therapies.

Click here to read the full article: https://www.thelancet.com/journals/langas/article/PIIS2468-1253(25)00190-6/fulltext

Continue this conversation on social!

Follow us today at...

https://bsky.app/profile/lancetgastrohep.bsky.social

https://www.linkedin.com/company/langastro/

https://instagram.com/thelancetgroup

https://facebook.com/thelancetmedicaljournal

https://youtube.com/thelancettv

Episode Artwork Dina Kao on a trial of lyophilised sterile faecal filtrate versus lyophilised conventional donor stool for recurrent Clostridiodes difficile infection 15:55 Episode Artwork Premysl Bercik on a double-blind crossover trial of gluten and wheat in IBS 16:21 Episode Artwork Julia Mayerle on the validation of plasma multimetabolite signatures for patients at risk of or with suspected pancreatic ductal adenocarcinoma 26:52 Episode Artwork Salvatore Piano on the global epidemiology of acute kidney injury in hospitalised patients with decompensated cirrhosis 19:05 Episode Artwork John Chia on the ASCOLT trial of adjuvant aspirin for colorectal cancer 13:29 Episode Artwork Hannes Hagström on screening for advanced liver fibrosis alongside retina scanning in people with type 2 diabetes 21:23 Episode Artwork Cathy Lu on intestinal ultrasound for assessing and monitoring Crohn's disease small bowel strictures 11:15 Episode Artwork Peter De Cruz on the PREDICT-UC trial of intensified versus standard dose infliximab for steroid-refractory acute severe ulcerative colitis 14:42 Episode Artwork Shahida Din and Beatriz Gros on the harms associated with receiving placebo in trials of drugs for inflammatory bowel disease 34:15 Episode Artwork Arndt Vogel on the NALIRICC trial of nanoliposomal irinotecan in pretreated advanced biliary tract cancer 18:23 Episode Artwork Nancy Baxter on the duration of colorectal cancer risk reduction with a complete colonoscopy 25:05 Episode Artwork Sanna Nybacka and Magnus Simrén on a trial of low FODMAP diets versus low carbohydrate diets in IBS 23:16 Episode Artwork Nuru Noor on the PROFILE trial of biomarker-stratified treatment in newly diagnosed Crohn's disease 19:55 Episode Artwork Yusuke Shimakawa on a simple score for hepatitis B treatment eligibility in Africa 20:54 Episode Artwork Mads Israelsen on validating the new steatotic liver disease nomenclature in people with excessive alcohol intake 16:39 Episode Artwork Louise Dye on the role of expectancy and gluten in non-coeliac gluten sensitivity 23:19 Episode Artwork Tzu-Chan Hong on the primary antibiotic resistance of Helicobacter pylori in the Asia-Pacific region 14:40 Episode Artwork Sarah Moen on metachronous colorectal cancer risk according to Lynch syndrome pathogenic variant after colectomy 14:45 Episode Artwork Anna Emilie Kann on the causes of mortality in patients with alcohol-related liver disease 16:19 Episode Artwork Robert Krouse on surgical versus non-surgical management of malignant bowel obstruction 16:31 Episode Artwork Marc Rothenberg on a trial of benralizumab in eosinophilic gastritis 14:29 Episode Artwork Michael Pavlides on non-invasive tests for predicting clinical outcomes in non-alcoholic fatty liver disease 17:41 Episode Artwork Jasmohan Bajaj on global disparities in mortality and liver transplantation in hospitalised patients with cirrhosis 12:48 Episode Artwork Adelina Artenie on the incidence of HIV and HCV in people who inject drugs 17:15 Episode Artwork Johan Burisch on the costs of inflammatory bowel disease in high-income settings 20:00